Nutropin Articles

Disappointing Results For Ares-Serono

12 November 1998

Pharmacia & Upjohn Posts Strong Growth For 3rd Qtr

3 November 1998

Genentech/Alkermes To File For Nutropin Depot

27 October 1998

Genentech & Alkermes Proceed With NDA For Nutropin Depot

23 October 1998

US Majors Post Strong Earnings For 3rd Quarter

15 October 1998

Sales Fall But Profits Rise At Ares-Serono

18 August 1998

Pharmacia & Upjohn Turnaround Continuing

31 July 1998

Stock Commentary Tokyo

16 July 1998

Rituxan Revenues Boost Genentech's 2nd Quarter

14 July 1998

Novo Nordisk And Ares-Serono Settle Growth Hormone Suit

19 May 1998

P&U Sales Up, Says Turnaround Is On Track

30 April 1998

Sales Fall But Profits Rise At Ares-Serono

16 April 1998

First-Quarter Sales Of Rituxan Boost Earnings At Genentech

15 April 1998

Ares-Serono Earnings Jump 64% For 1997

3 March 1998

Strong Rises In Sales, Net Income At Novo Nordisk

20 February 1998

P&U 1997 Sales Slide, Earnings Hit By Charges

18 February 1998

Strong $ Hits Ares-Serono's European Growth

16 January 1998

Sumitomo And Genentech Link-Up For hGH Products

13 January 1998

P&U Calls Halt To Off-Label Use Of Genotropin

4 December 1997

1998 - A "Critical" Year For P&U, Says CEO

3 December 1997

News In Brief

7 November 1997

3rd Qtr Sales And Earnings Take A Dip At Genentech

16 October 1997

Earnings Decline At Genentech In 1st Qtr

21 April 1997

FDA Approves Genentech's Nutropin AQ For Turner Syndrome

7 April 1997

New CPAC Approvals Include Two NCEs

7 April 1997

Novo Gets Go-Ahead For hGH

19 March 1997

"Highly Pleasing" 1996 Results At BTG

10 March 1997

Forecasts To 2002 For Euro Biotech Pharma Market

17 February 1997

Roche Enters New Product Phase With Bright Prospects

17 February 1997

Ares-Serono Sales Growth Still Led By Infertility Products

27 January 1997

FDA Year-End Approval Spate As Expected

6 January 1997

Lilly's Humatrope For Turner Syndrome

23 December 1996

Serostim Launched For Cachexia In USA

9 December 1996

Serono Labs' Saizen Approved In USA

21 October 1996

Net Income Falls At Pharmacia & Upjohn

12 August 1996

Earnings Decline At Genentech In 2nd Qtr

22 July 1996

Growth Hormone Is No "Fountain Of Youth"

22 April 1996

Revenues Up But Profits Down At Genentech

22 April 1996

Sweden's Pharma Market Expanded 12.7% In 1995

4 March 1996

Mixed Earnings But Strong Sales For US Companies

12 February 1996

Mixed Results For Q4 1995 From US Drug Majors

29 January 1996

Genentech And Roche Strengthen Relationship

6 November 1995

US Drug Cos Reveal Strong Growth In 1995 3rd Qtr

30 October 1995

US 3rd Qrt Results: Strong Gains For Pfizer, Lilly

23 October 1995

Yamanouchi Looks To New Products For Growth

23 October 1995

Genentech: Nutropin

9 October 1995

Strong Sales Growth For Biotechnology General

11 September 1995

Good Performance Forecast For Euro Drugmakers

26 June 1995

First World Launch Of Insulin-Like Growth Factor

13 February 1995

Genentech Setback In hGH Suit

12 December 1994

Pharmacia's Sales Decline But Profits Rise

21 November 1994

Genentech Presentation Pleases Analysts

17 October 1994

PROFITS MORE THAN DOUBLE AT GENENTECH

25 April 1994

GENENTECH'S hGH APPROVED IN USA

21 March 1994

NET PROFITS LEAP AT SUMITOMO PHARMA

7 March 1994

"EXCELLENT"RESULTS FROM GENENTECH

24 January 1994

NUTROPIN BACKED FOR FURTHER USE

1 November 1993

PMA WARNING ON FUTURE OF BIOTECHNOLOGY

27 September 1993

ANALYSTS SAY PROCORDIA SPLIT IS SOUND LOGIC

19 July 1993

ARES-SERONO PIPELINE OVERVIEW

31 May 1993

SWEDEN'S PHARMA MARKET IN 1992

5 April 1993

GENENTECH FILES COMPLAINT

22 March 1993

GENENTECH TO START TRIALS OF HER-2

27 January 1992

Novo Nordisk ups 2008 guidance